Key result
Elevated PWV marks vascular dysfunction in ~36% of pediatric terminal CKD patients, universally accompanying cardiac disease.
Why the study?
While pulse wave velocity is a well-studied marker of arterial stiffness and major cardiovascular events in adults, its assessment as a marker of cardiovascular risk in children with CKD required evaluation.
Does elevated pulse wave velocity correlate with cardiac disease (left ventricular hypertrophy) in pediatric patients with end-stage renal disease on dialysis?
Cohort (n=42)
No
Does elevated pulse wave velocity correlate with cardiac disease (left ventricular hypertrophy) in pediatric patients with end-stage renal disease on dialysis?
Elevated pulse wave velocity measured by echocardiography correlates strongly with left ventricular hypertrophy in pediatric patients with end-stage renal disease, serving as a potential non-invasive marker for high cardiovascular risk.
May flag concurrent cardiac disease via PWV in pediatric ESRD; hypothesis-generating for non-invasive risk stratification.
One of the main markers of arterial stiffness is pulse wave velocity (PWV). This parameter is well studied as a marker for end-organ damage in the adult population, being considered a strong predictor of major cardiovascular events. This study assessed PWV in children with chronic kidney disease (CKD) as a marker of cardiovascular risk. We conducted a prospective observational single-center cohort study of 42 consecutively pediatric patients (9-18 years old) with terminal CKD and dialysis, at the Hemodialysis Department of the "M. S. Curie" Hospital, Bucharest. We measured PWV by echocardiography in the ascending aorta (AscAo) and the descending aorta (DescAo), and we correlated them with left ventricular hypertrophy (LVH). Fifteen patients (35.7%) presented vascular dysfunction defined as PWV above the 95th percentile of normal values in the AscAo and/or DescAo. Cardiac disease (LVH/LV remodeling) was discovered in 32 patients (76.2%). All patients with vascular damage also had cardiac disease. Cardiac damage was already present in all patients with vascular disease, and the DescAo is more frequently affected than the AscAo (86.6% vs. 46.9%). Elevated PWV could represent an important parameter for identifying children with CKD and high cardiovascular risk.
No takes yet. Share an insight, caveat, or question.
Filip et al. (2021) conducted a cohort in End-Stage Renal Disease (ESRD) (n=42). Pulse wave velocity (PWV) measurement was evaluated on Vascular dysfunction (PWV above 95th percentile) and cardiac disease (LVH/LV remodeling). Elevated pulse wave velocity indicated vascular dysfunction in 35.7% of pediatric patients with terminal CKD, all of whom exhibited concurrent cardiac disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: